ACRV
ACRV clinical trials: Acrivon Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Acrivon Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 2
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ACRV on the catalyst calendar · ACRV registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Aug 12, 2027Sponsor estimate | NCT06667141Study of ACR-2316 in Specific Advanced Solid TumorsAcrivon Therapeutics · Specific Advanced Solid Tumors | ACRVLead | Phase 1/Phase 2 | Recruiting | Locked | Locked | Locked |
| May 30, 2027Sponsor estimate | NCT05548296A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaAcrivon Therapeutics · Endometrial Adenocarcinoma | ACRVLead | Phase 2 | Recruiting | Locked | Locked | Locked |
| Aug 23, 2028Sponsor estimate | NCT06597565A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCCH. Lee Moffitt Cancer Center and Research Institute · Head and Neck Squamous Cell Carcinoma | ACRVCollaborator | Phase 2 | Recruiting | Locked | Locked | Locked |
- Primary completion Aug 12, 2027Sponsor estimatePhase 1/Phase 2NCT06667141Study of ACR-2316 in Specific Advanced Solid TumorsAcrivon Therapeutics · Specific Advanced Solid TumorsRecruitingACRVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2027Sponsor estimatePhase 2NCT05548296A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaAcrivon Therapeutics · Endometrial AdenocarcinomaRecruitingACRVLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 23, 2028Sponsor estimatePhase 2NCT06597565A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCCH. Lee Moffitt Cancer Center and Research Institute · Head and Neck Squamous Cell CarcinomaRecruitingACRVCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner